Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer

NCT03088813 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

491

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: Irinotecan liposome injection
DRUG: Topotecan

Sponsor

Ipsen